News Archive

Pacific Biosciences is acquiring the Johns Hopkins spinout, which focuses in the area of sample prep. Local acclerator programs helped it grow.

Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies BALTIMORE, Md. – Jun. 23, 2021 –Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular

The new technologies born from academic research can be very promising, yet they are often very early stage. University spin-off companies are uniquely positioned to tackle the risks associated with new technologies emerging from academia by developing proofs of concept, functioning prototypes, and

There is a first time for everything, and entrepreneurs are the ones willing to make that first time happen. But making that first time happen isn’t easy, and that is surely an understatement. Being an entrepreneur means shouting out to anyone who will listen that their vision addresses a pressing

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (“Circulomics”), a Maryland-based

The third quarter continues the trend after two record-setting quarters for venture capital in Greater Washington, with steady money movement throughout the ecosystem, including $25 million to Bethesda software startup Mytonomy Inc. And more local VC firms are also raising funds, most recently with

TEDCO Portfolio Companies Spotlighted on Baltimore Business Journal

COLLEGE PARK, Md. (WJZ) — A professor at the University of Maryland in College Park has received new funding from two sources to continue research into CRISPR genome editing technologies, with the goal of enhancing crop production and feeding a growing global population, according to a university

COLLEGE PARK, Md. -- With two new funding sources, Yiping Qi, associate professor in the Department of Plant Science & Landscape Architecture (PSLA) at the University of Maryland (UMD), continues his work to expand the reach and utility of CRISPR gene editing technologies. Funded by the United

TEDCO, the Maryland Technology Development Corporation, awarded 45 grants to early-stage technology companies in the state that were hardest hit by the pandemic.

TEDCO, Maryland’s economic engine for technology companies, announced today its Rural and Underserved Business Recovery from Impact of COVID-19 (RUBRIC) program has awarded grants to 45 Maryland companies.

TEDCO, Maryland’s economic engine for technology companies, announced today its Rural and Underserved Business Recovery from Impact of COVID-19 (RUBRIC) program has awarded grants to 45 Maryland companies.

Astek Diagnostics is developing a platform to help doctors treating sepsis. Before getting the attention of the well-known SF accelerator, it previously received funding through TEDCO's Maryland Innovation Initaitive, and won national competitions.

TEDCO, the Maryland Technology Development Corporation, announced that Baltimore-based Astek Diagnostics Inc. was accepted into the Y Combinator.